Displaying 1 - 50 of 148 results
Released Company Title Industry Topic
01 Jun 2023
06:45 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Expansion of Clinical Collaboration with Roche to Evaluate VB10.16 in Combination with anti-PD-L1 in the next trial in Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
30 May 2023
18:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at Jefferies Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
26 May 2023
16:46 CEST
NYKODE THERAPEUTICS ASA Grant of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
12 May 2023
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q1 2023 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
11 May 2023
11:10 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
10 May 2023
17:25 CEST
NYKODE THERAPEUTICS ASA Disclosure of voting rights at AGM 20103010 Biotechnology Major shareholding notifications
08 May 2023
19:40 CEST
NYKODE THERAPEUTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 May 2023
19:40 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to announce financial results for the first quarter 2023 and host webcast presentation on May 12, 2023 20103010 Biotechnology Non-regulatory press releases
20 Apr 2023
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Apr 2023
08:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Annual Report 2022 20103010 Biotechnology Annual financial and audit Reports
18 Apr 2023
16:44 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics announces positive final results from its Phase 2 trial of VB10.16 in combination with PD-L1 inhibitor atezolizumab in advanced cervical cancer 20103010 Biotechnology Inside information
28 Feb 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report 4Q 2022 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Feb 2023
13:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to announce financial results for the fourth quarter 2022 and host webcast presentation on February 28, 2023 20103010 Biotechnology Non-regulatory press releases
13 Feb 2023
08:11 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – Flaggemelding Jan Haudemann-Andersen 20103010 Biotechnology Flagging
10 Feb 2023
06:45 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Collaboration with The GOG Foundation, Inc. to Conduct the VB-C-04 Trial in Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
07 Feb 2023
13:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference 20103010 Biotechnology Non-regulatory press releases
01 Feb 2023
13:31 CET
NYKODE THERAPEUTICS ASA Registration of new share capital 20103010 Biotechnology Total number of voting rights and capital
25 Jan 2023
18:45 CET
NYKODE THERAPEUTICS ASA Exercise of warrants and related transactions by primary insiders - Mandatory notification of trade primary insiders
09 Jan 2023
17:45 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Presentation at the 41st Annual J.P. Morgan Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
30 Dec 2022
09:25 CET
NYKODE THERAPEUTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
23 Dec 2022
11:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
22 Dec 2022
12:43 CET
NYKODE THERAPEUTICS ASA Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
20 Dec 2022
16:11 CET
NYKODE THERAPEUTICS ASA Registration of new share capital 20103010 Biotechnology Total number of voting rights and capital
20 Dec 2022
06:45 CET
NYKODE THERAPEUTICS ASA Nykode announces expanded clinical development plan for its lead cancer vaccine VB10.16 in HPV16-positive cancers 20103010 Biotechnology Non-regulatory press releases
19 Dec 2022
06:45 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics and Richter-Helm BioLogics Announce Strategic Manufacturing Partnership 20103010 Biotechnology Non-regulatory press releases
18 Dec 2022
22:45 CET
NYKODE THERAPEUTICS ASA Exercise of warrants by primary insider, transactions by a primary insider and a close associate, and disclosure of large shareholding 20103010 Biotechnology Mandatory notification of trade primary insiders
06 Dec 2022
16:45 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination With KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive Head and Neck Cancer 20103010 Biotechnology Non-regulatory press releases
23 Nov 2022
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report 3Q 2022 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
16 Nov 2022
16:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to announce financial results for the third quarter 2022 and host webcast presentation on November 23, 2022 20103010 Biotechnology Non-regulatory press releases
07 Nov 2022
16:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics presents additional efficacy analysis in Phase 2 study of VB10.16 in combination with atezolizumab in advanced cervical cancer 20103010 Biotechnology Non-regulatory press releases
07 Nov 2022
08:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to present at two upcoming investor conferences in November 20103010 Biotechnology Non-regulatory press releases
28 Oct 2022
08:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present a Poster on Interim Results from the Pre-planned Interim Analysis from the C-02 trial with VB10.16 in advanced cervical patients at the European Society of Gynaecological Oncology’s 23rd Annual Meeting (ESGO 2022) 20103010 Biotechnology Non-regulatory press releases
26 Oct 2022
16:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Presentation of Positive Immunogenicity Results from Phase 1/2a Study of VB10.NEO, an Individualized Therapeutic Cancer Vaccine, at the Neoantigen-Based Therapies Summit 20103010 Biotechnology Non-regulatory press releases
24 Oct 2022
17:58 CEST
NYKODE THERAPEUTICS ASA Mandatory notification of intra group transfer of shares by primary insider’s related party 20103010 Biotechnology Mandatory notification of trade primary insiders
27 Sep 2022
06:45 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Positive Results from the Phase 1/2 Open Label, Dose Escalation Trial of its T Cell Focused SARS-CoV-2 Vaccine Candidate 20103010 Biotechnology Inside information
09 Sep 2022
17:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to present at H.C. Wainwright 24th Annual Global Investment Conference 20103010 Biotechnology Non-regulatory press releases
08 Sep 2022
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to be included in the Oslo Børs Benchmark Index (OSEBX) and the Oslo Børs Mutual Fund Index (OSEFX) 20103010 Biotechnology Non-regulatory press releases
26 Aug 2022
16:44 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Mandatory notification for close associate of primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
24 Aug 2022
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report 2Q 2022 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Aug 2022
06:45 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to announce financial results for the first half of 2022 and host webcast presentation on August 24, 2022 20103010 Biotechnology Non-regulatory press releases
04 Jul 2022
20:50 CEST
NYKODE THERAPEUTICS ASA Grant of Share Options 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Jun 2022
15:54 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - approval and publication of prospectus and admission to trading on the Oslo Stock Exchange’s main list 20103010 Biotechnology Prospectus / admission document
13 Jun 2022
10:32 CEST
NYKODE THERAPEUTICS ASA Oslo Børs – Vedtak om opptak til handel – Nykode Therapeutics ASA 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
13 Jun 2022
10:32 CEST
NYKODE THERAPEUTICS ASA Oslo Børs - Decision on admission to trading – Nykode Therapeutics ASA 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
13 Jun 2022
08:35 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics appoints Klaus Edvardsen as Chief Development Officer 20103010 Biotechnology Non-regulatory press releases
08 Jun 2022
15:19 CEST
NYKODE THERAPEUTICS AS Application for transfer of shares admitted to trading on Euronext Growth to Oslo Børs 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
08 Jun 2022
15:19 CEST
NYKODE THERAPEUTICS AS Søknad om overføring av aksjer tatt opp til handel fra Euronext Growth til Oslo Børs 20103010 Biotechnology Annen informasjonspliktig regulatorisk informasjon
02 Jun 2022
15:45 CEST
NYKODE THERAPEUTICS AS Nykode Therapeutics ASA - Conversion to public limited liability company registered 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
01 Jun 2022
08:00 CEST
NYKODE THERAPEUTICS AS Nykode Therapeutics to Present at Jefferies Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
18 May 2022
16:00 CEST
NYKODE THERAPEUTICS ASA Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders